Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip G Conaghan

Showing results (51-60 of 503) with videos related to

Pageof 51
Sort By:
Spine|February 4, 2011
Internal construct validity of the Swiss Spinal Stenosis questionnaire: Rasch analysis of a disease-specific outcome measure for lumbar spinal stenosisChristine M Comer, Philip G Conaghan, Alan Tennant
Annals of the Rheumatic Diseases|March 12, 2017
Is MRI a predictive biomarker for clinical response to biologics in rheumatoid arthritis?Joshua F Baker, Mikkel Østergaard, Philip G Conaghan
The Journal of Rheumatology|March 18, 2017
IntroductionPhilip G Conaghan, Laure Gossec, Maria Antonietta D'Agostino
Clinical and Experimental Rheumatology|October 10, 2018
Update on magnetic resonance imaging and ultrasound in rheumatoid arthritisJoshua F Baker, Philip G Conaghan, Frederique Gandjbakhch
Rheumatology (Oxford, England)|December 12, 2012
Imaging tools in rheumatoid arthritis: ultrasound vs magnetic resonance imagingYork Kiat Tan, Mikkel Østergaard, Philip G Conaghan
BMC Musculoskeletal Disorders|January 30, 2023
Comparison of 3D quantitative osteoarthritis imaging biomarkers from paired CT and MR images: data from the IMI-APPROACH studyAlan Brett, Michael A Bowes, Philip G Conaghan
BMJ (Clinical Research Ed.)|March 4, 2008
Care and management of osteoarthritis in adults: summary of NICE guidancePhilip G Conaghan, John Dickson, Robert L Grant, et al.
Current Opinion in Rheumatology|April 3, 2009
The role of MRI in rheumatoid arthritis: research and clinical issuesJane E Freeston, Paul Bird, Philip G Conaghan
Journal of Inflammation Research|November 19, 2011
The role of the NLRP3 inflammasome in goutSarah R Kingsbury, Philip G Conaghan, Michael F McDermott
Expert Opinion on Drug Safety|May 15, 2013
Safety evaluation of leflunomide in rheumatoid arthritisHelen I Keen, Philip G Conaghan, Susan E Tett
Pageof 51

Showing results (51-60 of 503) with videos related to

Sort By:
Pageof 51
Spine|February 4, 2011
Internal construct validity of the Swiss Spinal Stenosis questionnaire: Rasch analysis of a disease-specific outcome measure for lumbar spinal stenosisChristine M Comer, Philip G Conaghan, Alan Tennant
Annals of the Rheumatic Diseases|March 12, 2017
Is MRI a predictive biomarker for clinical response to biologics in rheumatoid arthritis?Joshua F Baker, Mikkel Østergaard, Philip G Conaghan
The Journal of Rheumatology|March 18, 2017
IntroductionPhilip G Conaghan, Laure Gossec, Maria Antonietta D'Agostino
Clinical and Experimental Rheumatology|October 10, 2018
Update on magnetic resonance imaging and ultrasound in rheumatoid arthritisJoshua F Baker, Philip G Conaghan, Frederique Gandjbakhch
Rheumatology (Oxford, England)|December 12, 2012
Imaging tools in rheumatoid arthritis: ultrasound vs magnetic resonance imagingYork Kiat Tan, Mikkel Østergaard, Philip G Conaghan
BMC Musculoskeletal Disorders|January 30, 2023
Comparison of 3D quantitative osteoarthritis imaging biomarkers from paired CT and MR images: data from the IMI-APPROACH studyAlan Brett, Michael A Bowes, Philip G Conaghan
BMJ (Clinical Research Ed.)|March 4, 2008
Care and management of osteoarthritis in adults: summary of NICE guidancePhilip G Conaghan, John Dickson, Robert L Grant, et al.
Current Opinion in Rheumatology|April 3, 2009
The role of MRI in rheumatoid arthritis: research and clinical issuesJane E Freeston, Paul Bird, Philip G Conaghan
Journal of Inflammation Research|November 19, 2011
The role of the NLRP3 inflammasome in goutSarah R Kingsbury, Philip G Conaghan, Michael F McDermott
Expert Opinion on Drug Safety|May 15, 2013
Safety evaluation of leflunomide in rheumatoid arthritisHelen I Keen, Philip G Conaghan, Susan E Tett
Pageof 51